Skip Navigation



ToxSci Advance Access published online on April 27, 2005

Toxicological Sciences, doi:10.1093/toxsci/kfi186
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
86/2/309    most recent
kfi186v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kleinsasser, N. H.
Right arrow Articles by Richter, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kleinsasser, N. H.
Right arrow Articles by Richter, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences © The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received January 27, 2005
Accepted April 25, 2005

Genetic Toxicology

The tobacco alkaloid nicotine demonstrates genotoxicity in human tonsillar tissue and lymphocytes

Norbert H. Kleinsasser 1*, Andrea W. Sassen 1, Marzell P. Semmler 1, Ulrich A. Harréus 2, Anna-Katharina Licht 1, and Elmar Richter 3

1 Otolaryngology-Head and Neck Surgery, University of Regensburg, Germany
2 Otolaryngology-Head and Neck Surgery, Ludwig-Maximilians University Munich, Germany
3 Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians University Munich, Germany

* To whom correspondence should be addressed.
Norbert H. Kleinsasser, E-mail: norbert.kleinsasser{at}klinik.uni-regensburg.de


   Abstract

Recent studies suggest a direct contribution of nicotine, the addictive component of tobacco and tobacco smoke, to human carcinogenesis. To assess the genotoxicity of nicotine, the DNA damaging effect on human lymphocytes and target cells from lymphatic tissue of the palatine tonsils from 10 healthy patients was tested with the alkaline single cell microgel electrophoresis (Comet) assay. The degree of DNA migration, a measure of possible DNA single strand breaks, alkali labile sites and incomplete excision repair sites, was expressed as the Olive tail moment, the percentage of DNA in the tail and the tail length. One hour exposure to nicotine at 0.125, 0.25, 0.5, 1, 2, and 4 mM induced a statistically significant dose-dependent increase of DNA migration up to 3.8-fold and 3.2-fold in tonsillar cells and lymphocytes, respectively. The lowest concentration eliciting a significant DNA damage was 0.5 mM nicotine. The genotoxic effect was confirmed in a second series of experiments using nicotine of high purity from two different suppliers. There were no significant differences between both series excluding artifacts due to the source of nicotine. Finally, DNA damage by nicotine was compared in cells incubated in media strictly adjusted to neutral pH with non adjusted media becoming alkaline with increasing nicotine concentrations. Again no differences as concerns DNA migration were observed. The data indicate that nicotine expresses significant direct genotoxic effects in human target cells in vitro. However, no differences in DNA damage were observed in cells from smokers and nonsmokers incubated without nicotine. The lack of higher DNA damage in smokers compared to nonsmokers could be a question of nicotine dose, rapid DNA repair or interactions with other smoke constituents. These results require further investigations on the contribution of nicotine to tobacco carcinogenesis.

Keywords: Genotoxicity; nicotine; Comet assay; human target cells.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ther Adv Respir DisHome page
G. S. Maritz
Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring
Therapeutic Advances in Respiratory Disease, August 1, 2009; 3(4): 193 - 210.
[Abstract] [PDF]


Home page
J Health PsycholHome page
K. H. Ginzel, G. S. Maritz, D. F. Marks, M. Neuberger, Jim. R. Pauly, J. R. Polito, R. Schulte-Hermann, and T. A. Slotkin
Critical Review: Nicotine for the Fetus, the Infant and the Adolescent?
J Health Psychol, March 1, 2007; 12(2): 215 - 224.
[Abstract] [PDF]


Home page
Toxicol SciHome page
A. W. Sassen, E. Richter, M. P. Semmler, U. A. Harreus, F. Gamarra, and N. H. Kleinsasser
Genotoxicity of Nicotine in Mini-Organ Cultures of Human Upper Aerodigestive Tract Epithelia
Toxicol. Sci., November 1, 2005; 88(1): 134 - 141.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
H. Hoffmann, J. Hogel, and G. Speit
The effect of smoking on DNA effects in the comet assay: a meta-analysis
Mutagenesis, November 1, 2005; 20(6): 455 - 466.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.